• Kathmandu Univ Med J (KUMJ) · Jan 2011

    Comparative Study

    Tricuspid valve repair: DeVega's tricuspid annuloplasty in moderate secondary tricuspid regurgitation.

    • S Pradhan, N C Gautam, Y M Singh, S Shakya, R B Timala, J Sharma, and B Koirala.
    • Department of Cardiac Surgery, Shahid Gangagal National Heart Center, Bansbari, Kathmandu. sidpradhan72@gmail.com
    • Kathmandu Univ Med J (KUMJ). 2011 Jan 1;9(33):64-8.

    BackgroundModerate secondary tricuspid incompetence has variable natural history if left unattended during mitral valve surgery. Recent data suggest progression of the secondary tricuspid incompetence over time.Secondary moderate tricuspid regurgitation in rheumatic mitral valve disease may regress after mitral valve surgery without direct intervention.ObjectivesThe present study was done to assess early result of DeVega tricuspid valve annuloplasty amongst those with moderate tricuspid regurgitation due to rheumatic mitral valve disease.MethodsGroup I(mitral value replacement with tricuspid repair) and group II (mitral value replacement only).The two groups were followed up at three months post-operatively and evaluated for their functional class and echocardiography variables.ResultsThere were 43 patients who underwent mitral valve replacement with moderate tricuspid regurgitation. 23 underwent mitral valve replacement with tricuspid repair group (Group 1). Most of the patients were women (28/43). The mean age was 31.4 + 14.8 and 25.13 + 9.4 years. Group I had 21(91.3%) and Group II had 17 (85%) in NYHA class III and IV. The pre-operative echocardiographic cardiac left ventricular and left atrial dimensions, Left ventricular function and valve lesions were statistically similar for both groups, except PASP was higher amongst tricuspid repair (Group 1: 38.60 + 12.75 mHg, Group 2: 61.52 + 19.76 mmHg; p equals or less than 0.05). At three month review after surgery, four patients were in NYHA II amongst those without tricuspid repair (Group II), whilst the rest were in NYHA I. Left ventricular dimensions, Left Ventricular function and valve prosthetic valve function were similar between groups. Eleven (47.8%) patients in Group I and only five (25%) of Group II had trace or less TR at the follow-up. This was found to be statistically significant on chi square test (p less than 0.05). There were 7 (16.2%) patients who had persistent moderate TR. Higher PASP and larger LV dimensions at three months were predictive of persistent moderate TR.ConclusionMitral valve replacement does decrease the severity of tricuspid regurgitation amongst those with secondary moderate tricuspid regurgitation by at least one grade, but DeVega's annuloplasty confers a better repair result.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.